Medline Finalizes Acquisition Of Hudson RCI
Medline has officially completed the acquisition of a large share of Hudson RCI, a manufacturer of respiratory products and consumables from Telefex. The sale, which was initially announced in May 2021, brings the addition of Hudson RCI’s active humidification, oxygen and aerosol therapy, incentive spirometer products and non-invasive ventilation (NIV) offerings under the Medline umbrella.
Medline, which has emphasized its respiratory product offerings since the onset of the COVID-19 pandemic with great success, believes the acquisition will continue to help the company meet the elevated needs of healthcare clients.
“The addition of the highly-regarded Hudson RCI line of products broadens our portfolio of world-class respiratory solutions that are designed to empower best practices and deliver the uncompromising quality and performance required to care for the complex needs of patients,” says Donna Mosakowski, Medline division vice president.
Disclaimer: Please note that Facebook comments are posted through Facebook and cannot be approved, edited or declined by CleanLink.com. The opinions expressed in Facebook comments do not necessarily reflect those of CleanLink.com or its staff. To find out more about Facebook commenting please read the Conversation Guidelines.